Inventor
CHAN KATRINA
US47 patents
⚠️ This page may combine multiple inventors who share the name “CHAN KATRINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REN PINGDA
14 patentsUS8193182B2Jun 5, 2012
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
REN PINGDA93 citations99
US9096611B2Aug 4, 2015
Kinase inhibitors and methods of use
REN PINGDA65 citations98
US8604032B2Dec 10, 2013
Chemical compounds, compositions and methods for kinase modulation
REN PINGDA48 citations98
US8569323B2Oct 29, 2013
Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof
REN PINGDA61 citations98
US9127000B2Sep 8, 2015
Heterocyclic compounds and uses thereof
REN PINGDA30 citations94
US9085560B2Jul 21, 2015
Heterocyclic compounds and uses thereof
REN PINGDA37 citations94
US8901133B2Dec 2, 2014
Heterocyclic compounds and uses thereof
REN PINGDA44 citations94
US8703777B2Apr 22, 2014
Certain chemical entities, compositions and methods
REN PINGDA36 citations94
US8703778B2Apr 22, 2014
Heterocyclic kinase inhibitors
REN PINGDA20 citations93
US8785456B2Jul 22, 2014
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
REN PINGDA25 citations92
US8993580B2Mar 31, 2015
Benzothiazole kinase inhibitors and methods of use
REN PINGDA11 citations84
US9096590B2Aug 4, 2015
Substituted benzoxazoles as PI3 kinase inhibitors
REN PINGDA5 citations73
US8476431B2Jul 2, 2013
Benzoxazole kinase inhibitors and methods of use
REN PINGDA3 citations63
US8476282B2Jul 2, 2013
Benzoxazole kinase inhibitors and methods of use
REN PINGDA3 citations63
INTELLIKINE LLC
12 patentsUS9522146B2Dec 20, 2016
Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof
INTELLIKINE LLC10 citations92
US9216982B2Dec 22, 2015
Certain chemical entities, compositions and methods
INTELLIKINE LLC8 citations92
US9828378B2Nov 28, 2017
Kinase inhibitors and methods of use
INTELLIKINE LLC6 citations84
US9296742B2Mar 29, 2016
Heterocyclic kinase inhibitors
INTELLIKINE LLC6 citations84
US9206182B2Dec 8, 2015
Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereof
INTELLIKINE LLC8 citations84
US9637492B2May 2, 2017
Benzothiazole kinase inhibitors and methods of use
INTELLIKINE LLC2 citations73
US9655892B2May 23, 2017
Certain chemical entities, compositions and methods
INTELLIKINE LLC1 citations63
US9345706B2May 24, 2016
Benzoxazole kinase inhibitors and methods of use
INTELLIKINE LLC1 citations63
US11433065B2Sep 6, 2022
Certain chemical entities, compositions and methods
INTELLIKINE LLC0 citations62
US9822131B2Nov 21, 2017
Certain chemical entities, compositions and methods
INTELLIKINE LLC0 citations52
US9790228B2Oct 17, 2017
Heterocyclic kinase inhibitors
INTELLIKINE LLC1 citations52
US9359352B2Jun 7, 2016
Substituted benzimidazoles as PI3 kinase inhibitors
INTELLIKINE LLC0 citations52
INFINITY PHARMACEUTICALS INC
9 patentsUS9181221B2Nov 10, 2015
Chemical compounds, compositions and methods for kinase modulation
INFINITY PHARMACEUTICALS INC64 citations98
US8940742B2Jan 27, 2015
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC35 citations94
US9388183B2Jul 12, 2016
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC19 citations93
US9255108B2Feb 9, 2016
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC21 citations93
US9115141B2Aug 25, 2015
Substituted isoquinolinones and methods of treatment thereof
INFINITY PHARMACEUTICALS INC27 citations93
US9605003B2Mar 28, 2017
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC3 citations73
US9546180B2Jan 17, 2017
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC2 citations73
US9738644B2Aug 22, 2017
Chemical compounds, compositions and methods for kinase modulation
INFINITY PHARMACEUTICALS INC0 citations52
US9718815B2Aug 1, 2017
Heterocyclic compounds and uses thereof
INFINITY PHARMACEUTICALS INC0 citations52
PLEXXIKON INC
6 patentsUS9718847B2Aug 1, 2017
Heterocyclic compounds and uses thereof
PLEXXIKON INC33 citations94
US9676748B2Jun 13, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC23 citations94
US9938273B2Apr 10, 2018
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC17 citations85
US10301280B2May 28, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC6 citations84
US10227357B2Mar 12, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC7 citations84
US10519177B2Dec 31, 2019
Heterocyclic compounds and uses thereof
PLEXXIKON INC4 citations73